C4 Therapeutics's total assets for Q3 2024 were $349.60M, a decrease of -7.04% from the previous quarter. CCCC total liabilities were $133.62M for the fiscal quarter, a 0.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.